The retina is an emerging CNS target for potential noninvasive diagnosis and tracking of
Alzheimer's disease (AD). Studies have identified the pathological hallmarks of AD …

In the last 20 years, research focused on developing retinal imaging as a source of potential
biomarkers for Alzheimer's disease and other neurodegenerative diseases, has increased …

Retinal imaging technology is rapidly advancing and can provide ever-increasing amounts
of information about the structure, function and molecular composition of retinal tissue in …

Cognitive impairment and dementia are major medical, social, and economic public health
issues worldwide with significant implications for life quality in older adults. The leading …

The last decade has seen a substantial increase in research focused on the identification,
development, and validation of diagnostic and prognostic retinal biomarkers for Alzheimer's …

Background Alzheimer's Disease (AD) can cause degeneration in the retina and optic nerve
either directly, as a result of amyloid beta deposits, or secondarily, as a result of the …

Transport of β-amyloid from brain to eye causes retinal degeneration in Alzheimer’s disease |
Journal of Experimental Medicine | Rockefeller University Press Skip to Main Content …

As the most common form of dementia, Alzheimer's disease (AD) is characterized by
progressive cognitive impairments and constitutes a major social burden. Currently, the …

Mild cognitive impairment (MCI), representing the 'transitional zone'between normal
cognition and dementia, has become a novel topic in clinical research. Although early …

Importance Retinal biomarkers reflecting in vivo brain Alzheimer disease (AD) pathologic
abnormalities could be a useful tool for screening cognitively normal (CN) individuals at the …